Qantas (ASX:QAN) sells international flights for July

The airline throws open the gates, but here's what you need to do before going on that long-awaited overseas trip.

| More on:
travel shares and IPO represented by man holding passport and wads of cash

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Qantas Airways Limited (ASX: QAN) has started selling international flights for July and beyond.

The airline had previously ruled out resumption of flights to COVID-19 hotspots like the United States and United Kingdom until at least October. It had also planned a gradual restart of international services with Singapore, Hong Kong and Tokyo resuming from the end of March.

But now all that seems to have been thrown out the window, with almost the entire international catalogue available to book from July onwards.

The Motley Fool has confirmed this on the Qantas website, able to see a $1,669 return fare to Los Angeles departing on 2 July.

"We continue to review and update our international schedule in response to the developing COVID-19 situation," a Qantas spokesperson told The Motley Fool.

"Recently we have aligned the selling of our international services to reflect our expectation that international travel will begin to restart from July 2021."

Qantas website showing a flight between Sydney and Los Angeles.

A needle (or two) before that overseas trip

The airline's chief executive Alan Joyce had previously flagged that coronavirus vaccination would be compulsory for international passengers.

"Talking to my colleagues in other airlines around the globe, I think it's going to be a common theme," he said in November.

"What we're looking at is how you can have a vaccination passport, an electronic version of it, that certifies what the vaccine is. Is it acceptable to the country that you're travelling to?"

Qantas' may have become emboldened due to the prospect of a March rollout of vaccines in Australia.

Federal health minister Greg Hunt last week pulled forward his previous target of having the nation vaccinated by the end of the year.

"We expect that Australians will be fully vaccinated by the end of October – on the basis it's free, it's universal, and it's entirely voluntary," he said.

"But we want to urge as many Australians to be vaccinated, and we've seen some very heartening reports over the weekend of an expected uptake of up to 80 per cent."

Not all international routes are back though

While most international routes seem to have resumed, one popular destination is still a no-go zone.

Travel website Executive Traveller reported Qantas' service to New York City seems to be missing in the July reboot, as is Sydney to Santiago.

The publication also noted the Sydney-Hong Kong route is starting with a once daily schedule, rather than the pre-COVID frequency of twice daily.

Qantas previously estimated its domestic business by Christmas would be about 60% of pre-COVID levels. But the international arm had been at a standstill since March when the pandemic quashed demand.

Qantas shares have been down in the past month due to the resurgence of the virus in Sydney and Melbourne. At the time of writing, the Qantas share price is trading down 1.63% at $4.83.

Motley Fool contributor Tony Yoo owns shares of Qantas Airways Limited. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A man has computer-generated images rushing through his head indicating an AI (Artificial Intelligence) concept of a communication network.
Technology Shares

ASX investors are obsessed with Nvidia shares! Here's why

The global chipmaker reported a 94% increase in annual revenue in the third quarter.

Read more »

A man wearing a red jacket and mountain hiking clothes stands at the top of a mountain peak and looks out over countless mountain ranges.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another disappointing day for ASX investors this Thursday.

Read more »

two racing cars battle to take first place on a formula one track with one tailing the the leader and looking to overtake the car.
Opinions

Down 21% in 2024. This ASX 300 stock looks like a money-making monster

Profits are expected to plunge, but the future could still be bright.

Read more »

A businesswoman exhales a deep sigh after receiving bad news, and gets on with it.
52-Week Lows

Down 68% from highs, this ASX 200 stock just hit a 4-year low. Time to pounce?

Is this beaten down stock a buy? Let's see what one leading broker is saying.

Read more »

two men smiling with a laptop in front of them, symbolising a rising share price.
Share Gainers

Why Pinnacle, PWR, Race Oncology, and Vulcan shares are flying today

These shares are having a good session on Thursday. But why?

Read more »

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Accent, Sayona Mining, Web Travel, and Weebit Nano shares are dropping today

These shares are having a tough time on Thursday. Why are they being sold off?

Read more »

Modern accountant woman in a light business suit in modern green office with documents and laptop.
Share Market News

Insider buying alert: 3 ASX 200 shares directors are snapping up right now

Directors in some of Australia's blue-chip businesses aren't shying away from the market.

Read more »

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Broker Notes

Guess which beaten down ASX share is rocketing 11% today

Why are investors buying this beaten down stock? Let's find out.

Read more »